StockData
VivoSim Labs, INC. logo

VivoSim Labs, INC. (VIVS) stock

VIVSNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$0.12−0.00 (-0.08%)

Close on Nov 18, 2026Market cap $383.32KP/E –Yield –

VivoSim Labs market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

VivoSim Labs's market cap was $493.84K on Nov 11, 2026, against $5.84M a year earlier. Over the last 5 years it ranged from $493.84K to $32.73M, with a median of $9.24M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$493.84K-89.5%
2025Dec 31, 2025$4.72M-33.2%
2024Dec 31, 2024$7.07M-27.0%
2023Dec 29, 2023$9.68M-21.2%
2022Dec 30, 2022$12.29M-61.1%
2021Dec 31, 2021$31.60M-61.8%
2020Dec 31, 2020$82.81M+76.4%
2019Dec 31, 2019$46.96M-57.5%
2018Dec 31, 2018$110.59M-22.8%
2017Dec 29, 2017$143.26M-54.9%
2016Dec 30, 2016$317.83M+38.2%
2015Dec 31, 2015$229.90M-60.6%
2014Dec 31, 2014$582.93M-10.0%
2013Dec 31, 2013$647.99M+1010.4%
2012Dec 31, 2012$58.36M–

More VivoSim Labs figures

See a number that looks wrong?